vs
PREFORMED LINE PRODUCTS CO（PLPC）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是PREFORMED LINE PRODUCTS CO的1.8倍（$303.4M vs $173.1M），Sotera Health Co净利率更高（11.5% vs 4.9%，领先6.6%），Sotera Health Co同比增速更快（4.6% vs 3.6%），Sotera Health Co自由现金流更多（$52.4M vs $11.8M），过去两年PREFORMED LINE PRODUCTS CO的营收复合增速更高（10.8% vs 10.6%）
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
PLPC vs SHC — 直观对比
营收规模更大
SHC
是对方的1.8倍
$173.1M
营收增速更快
SHC
高出1.0%
3.6%
净利率更高
SHC
高出6.6%
4.9%
自由现金流更多
SHC
多$40.6M
$11.8M
两年增速更快
PLPC
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $173.1M | $303.4M |
| 净利润 | $8.4M | $34.8M |
| 毛利率 | 29.8% | 54.7% |
| 营业利润率 | 6.8% | 23.2% |
| 净利率 | 4.9% | 11.5% |
| 营收同比 | 3.6% | 4.6% |
| 净利润同比 | -19.3% | 182.8% |
| 每股收益（稀释后） | $1.72 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLPCSHC
| Q4 25 | $173.1M | $303.4M | ||
| Q3 25 | $178.1M | $311.3M | ||
| Q2 25 | $169.6M | $294.3M | ||
| Q1 25 | $148.5M | $254.5M | ||
| Q4 24 | $167.1M | $290.2M | ||
| Q3 24 | $147.0M | $285.5M | ||
| Q2 24 | $138.7M | $276.6M | ||
| Q1 24 | $140.9M | $248.2M |
净利润PLPCSHC
| Q4 25 | $8.4M | $34.8M | ||
| Q3 25 | $2.6M | $48.4M | ||
| Q2 25 | $12.7M | $8.0M | ||
| Q1 25 | $11.5M | $-13.3M | ||
| Q4 24 | $10.5M | $12.3M | ||
| Q3 24 | $7.7M | $17.0M | ||
| Q2 24 | $9.4M | $8.8M | ||
| Q1 24 | $9.6M | $6.3M |
毛利率PLPCSHC
| Q4 25 | 29.8% | 54.7% | ||
| Q3 25 | 29.7% | 57.0% | ||
| Q2 25 | 32.7% | 56.6% | ||
| Q1 25 | 32.8% | 53.2% | ||
| Q4 24 | 33.3% | 56.6% | ||
| Q3 24 | 31.1% | 55.4% | ||
| Q2 24 | 31.9% | 55.2% | ||
| Q1 24 | 31.3% | 51.2% |
营业利润率PLPCSHC
| Q4 25 | 6.8% | 23.2% | ||
| Q3 25 | 7.4% | 23.4% | ||
| Q2 25 | 10.1% | 6.4% | ||
| Q1 25 | 8.8% | -5.8% | ||
| Q4 24 | 10.5% | 30.0% | ||
| Q3 24 | 7.1% | 28.2% | ||
| Q2 24 | 8.1% | 27.8% | ||
| Q1 24 | 8.2% | 21.4% |
净利率PLPCSHC
| Q4 25 | 4.9% | 11.5% | ||
| Q3 25 | 1.5% | 15.5% | ||
| Q2 25 | 7.5% | 2.7% | ||
| Q1 25 | 7.8% | -5.2% | ||
| Q4 24 | 6.3% | 4.2% | ||
| Q3 24 | 5.2% | 6.0% | ||
| Q2 24 | 6.8% | 3.2% | ||
| Q1 24 | 6.8% | 2.5% |
每股收益（稀释后）PLPCSHC
| Q4 25 | $1.72 | $0.12 | ||
| Q3 25 | $0.53 | $0.17 | ||
| Q2 25 | $2.56 | $0.03 | ||
| Q1 25 | $2.33 | $-0.05 | ||
| Q4 24 | $2.13 | $0.05 | ||
| Q3 24 | $1.54 | $0.06 | ||
| Q2 24 | $1.89 | $0.03 | ||
| Q1 24 | $1.94 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $344.6M |
| 总债务越低越好 | $38.3M | $2.1B |
| 股东权益账面价值 | $475.5M | $606.0M |
| 总资产 | $653.6M | $3.3B |
| 负债/权益比越低杠杆越低 | 0.08× | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资PLPCSHC
| Q4 25 | — | $344.6M | ||
| Q3 25 | — | $299.2M | ||
| Q2 25 | — | $332.4M | ||
| Q1 25 | — | $304.4M | ||
| Q4 24 | — | $277.2M | ||
| Q3 24 | — | $306.7M | ||
| Q2 24 | — | $246.1M | ||
| Q1 24 | — | $261.1M |
总债务PLPCSHC
| Q4 25 | $38.3M | $2.1B | ||
| Q3 25 | $36.0M | $2.1B | ||
| Q2 25 | $31.8M | $2.2B | ||
| Q1 25 | $29.1M | $2.2B | ||
| Q4 24 | $20.8M | $2.2B | ||
| Q3 24 | $27.2M | $2.2B | ||
| Q2 24 | $31.6M | $2.2B | ||
| Q1 24 | $55.0M | $2.2B |
股东权益PLPCSHC
| Q4 25 | $475.5M | $606.0M | ||
| Q3 25 | $466.3M | $550.5M | ||
| Q2 25 | $460.7M | $511.3M | ||
| Q1 25 | $435.8M | $414.1M | ||
| Q4 24 | $422.3M | $404.9M | ||
| Q3 24 | $429.0M | $470.2M | ||
| Q2 24 | $416.2M | $422.8M | ||
| Q1 24 | $413.4M | $429.4M |
总资产PLPCSHC
| Q4 25 | $653.6M | $3.3B | ||
| Q3 25 | $644.6M | $3.2B | ||
| Q2 25 | $631.5M | $3.2B | ||
| Q1 25 | $592.5M | $3.1B | ||
| Q4 24 | $573.9M | $3.1B | ||
| Q3 24 | $592.0M | $3.1B | ||
| Q2 24 | $572.6M | $3.1B | ||
| Q1 24 | $586.1M | $3.1B |
负债/权益比PLPCSHC
| Q4 25 | 0.08× | 3.53× | ||
| Q3 25 | 0.08× | 3.89× | ||
| Q2 25 | 0.07× | 4.34× | ||
| Q1 25 | 0.07× | 5.36× | ||
| Q4 24 | 0.05× | 5.49× | ||
| Q3 24 | 0.06× | 4.73× | ||
| Q2 24 | 0.08× | 5.26× | ||
| Q1 24 | 0.13× | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.9M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $11.8M | $52.4M |
| 自由现金流率自由现金流/营收 | 6.8% | 17.3% |
| 资本支出强度资本支出/营收 | 5.9% | 16.7% |
| 现金转化率经营现金流/净利润 | 2.60× | 2.96× |
| 过去12个月自由现金流最近4个季度 | $33.3M | $149.2M |
8季度趋势，按日历期对齐
经营现金流PLPCSHC
| Q4 25 | $21.9M | $103.1M | ||
| Q3 25 | $18.9M | $71.2M | ||
| Q2 25 | $26.9M | $57.4M | ||
| Q1 25 | $5.7M | $55.5M | ||
| Q4 24 | $24.1M | $55.7M | ||
| Q3 24 | $9.4M | $97.5M | ||
| Q2 24 | $28.3M | $61.3M | ||
| Q1 24 | $5.8M | $9.7M |
自由现金流PLPCSHC
| Q4 25 | $11.8M | $52.4M | ||
| Q3 25 | $8.3M | $35.0M | ||
| Q2 25 | $18.6M | $26.2M | ||
| Q1 25 | $-5.3M | $35.6M | ||
| Q4 24 | $20.6M | $-10.2M | ||
| Q3 24 | $5.8M | $61.1M | ||
| Q2 24 | $24.6M | $19.4M | ||
| Q1 24 | $1.8M | $-25.2M |
自由现金流率PLPCSHC
| Q4 25 | 6.8% | 17.3% | ||
| Q3 25 | 4.7% | 11.2% | ||
| Q2 25 | 10.9% | 8.9% | ||
| Q1 25 | -3.6% | 14.0% | ||
| Q4 24 | 12.3% | -3.5% | ||
| Q3 24 | 3.9% | 21.4% | ||
| Q2 24 | 17.7% | 7.0% | ||
| Q1 24 | 1.3% | -10.2% |
资本支出强度PLPCSHC
| Q4 25 | 5.9% | 16.7% | ||
| Q3 25 | 6.0% | 11.6% | ||
| Q2 25 | 4.9% | 10.6% | ||
| Q1 25 | 7.4% | 7.8% | ||
| Q4 24 | 2.1% | 22.7% | ||
| Q3 24 | 2.4% | 12.7% | ||
| Q2 24 | 2.7% | 15.2% | ||
| Q1 24 | 2.8% | 14.1% |
现金转化率PLPCSHC
| Q4 25 | 2.60× | 2.96× | ||
| Q3 25 | 7.21× | 1.47× | ||
| Q2 25 | 2.12× | 7.21× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 2.30× | 4.52× | ||
| Q3 24 | 1.22× | 5.73× | ||
| Q2 24 | 3.02× | 7.00× | ||
| Q1 24 | 0.60× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLPC
暂无分部数据
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
